Liana Ling Outlines the $5/Day Meta Ads Which Stop Wasted Spend
Live Call on January 21 at 7 PM EST at the Survive & Thrive Summit. A Simple Way to Stop Guessing and Regain Control of Lead Flow
New York, NY (FreePR.org) -- Meta ads can go two ways. One, they either drain money with nothing to show for it. Two, they quietly fill your calendar while you stay in control of the numbers.
The stress isn’t “running ads.” It’s running ads without certainty.
Budgets get boosted. Tests get launched. Agencies get hired. But the pipeline still feels unreliable.
This is why Liana Ling is returning to the Survive & Thrive Summit on January 21. Her talk title is, “The $5/Day Meta Ads That Build Your Pipeline.” She will be focusing on making Meta ads easier to trust and easier to manage.
This live call is for the business owner who wants their pipeline to feel steadier, with less complexity.
When Ads Create Pressure Instead of Predictability
It’s hard to trust your marketing when every ad decision feels like a gamble.
Liana’s approach introduces a small daily rhythm designed to make Meta ads easier to read, manage, and rely on.
It’s not a massive funnel rebuild. Nor is it a “test everything and hope” approach.
What This Live Call Helps You Fix Immediately
Liana’s call centers on a pipeline you can build using small daily ads creating clarity instead of confusion.
On the live call, you’ll see how to:
Spend Control: How to stop wasting money on ads which never produce usable data.
Pipeline Feed: Five $5/day frameworks building awareness, validate offers, and bring in steady leads.
Dollar Efficiency: A simple ad structure making every $5/day drive leads and conversions.
Buyer Targeting: How to reach higher-intent buyers without burning budget on the wrong audiences.
Momentum Building: A repeatable daily rhythm turning small ad wins into consistent pipeline growth.
Leave knowing which numbers matter, which ads to keep running, and which ones to stop touching.
From there, the pipeline becomes something you can manage, not guess at.
Event Details
When: January 21, 2026 at 7PM EST / 4PM PST
Format: Virtual (Live on Zoom + Weekend Replay)
Cost: FREE Access Here https://members.bestbusinesscoach.ca/survive-and-thrive-business-summit/
About BestBusinessCoach.ca
Daryl Urbanski is the founder of BestBusinessCoach.ca and the host of The Best Business Podcast. He is a business strategist who helps entrepreneurs grow their businesses using proven methods.
He brings back the Survive & Thrive Summit, uniting a group of 15 world-class experts. Together, they focus on applying the 8 Critical Success Factors behind stable, resilient growth.
Learn more or join for FREE at
https://members.bestbusinesscoach.ca/survive-and-thrive-business-summit/
###
Contact Information:
Contact Information:
For media inquiries, additional info, or to arrange an interview with Daryl Urbanski, please contact:
BestBusinessCoach.ca
Email: skillsforsuccess@bestbusinesscoach.ca
Sponsor Message
By choosing Canadian pharmacies, millions of Americans gain access to lower-cost medications like Lipitor, Crestor, and Nexium. Patients living with chronic conditions rely on Humalog and Lantus for diabetes management, and on Advair Diskus and Ventolin inhalers for respiratory issues like asthma and COPD. Mental health medications such as Zoloft, Prozac, and Abilify provide critical support for those battling depression, anxiety, or bipolar disorder, while blood thinners like Eliquis, Plavix, and Xarelto are crucial for preventing stroke and other heart-related complications. Medications such as Celebrex for managing pain and inflammation and Synthroid for thyroid health are frequently sought after. In addition, medications such as Viagra and Cialis are commonly used to treat erectile dysfunction, while Januvia aids in managing Type 2 diabetes. Wakefulness-promoting drugs such as Provigil and Nuvigil are invaluable for people with narcolepsy or severe daytime sleepiness. Canadian pharmacies provide American patients with affordable solutions, including Cymbalta for nerve pain and Aricept for Alzheimer's.
